The Journal of Bone and Joint Surgery (American). 2005;87:1323-1331.
doi:10.2106/JBJS.C.00913
© 2005 The Journal of Bone and Joint Surgery, Inc.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vögelin, E.
Right arrow Articles by Lieberman, J.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vögelin, E.
Right arrow Articles by Lieberman, J.R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?

Healing of a Critical-Sized Defect in the Rat Femur with Use of a Vascularized Periosteal Flap, a Biodegradable Matrix, and Bone Morphogenetic Protein

E. Vögelin, MD1, N.F. Jones, MD1, J.I. Huang, MD1, J.H. Brekke, DDS2 and J.R. Lieberman, MD1

1 Department of Orthopaedic Surgery, Division of Plastic and Reconstructive Surgery, and UCLA Hand Center, University of California at Los Angeles, 200 UCLA Medical Plaza, Suite 140, Los Angeles, CA 90095. E-mail address for N.F. Jones: njones{at}mednet.ucla.edu
2 Kensey Nash Corporation, 325 Lake Avenue South, Duluth, MN 55802

Investigation performed at the Department of Orthopaedic Surgery and Division of Plastic and Reconstructive Surgery, University of California at Los Angles, Los Angeles, California

Background: The purpose of this study was to evaluate the osseous healing of a critical-sized femoral defect in a rat model with use of recombinant human bone morphogenetic protein-2 (rhBMP-2), a matrix fabricated of D,D-L,L-polylactic and hyaluronan acid (OPLA-HY), and a vascularized periosteal flap.

Methods: The carrier matrix OPLA-HY with or without rhBMP-2 was implanted in a 1-cm-long femoral defect and secured with a plate and screws. In some groups, a vascularized periosteal flap was harvested from the medial surface of the tibia. In group 1, the femoral defects in the animals were filled with the OPLA-HY matrix alone; in group 2, the OPLA-HY matrix was covered by the vascularized periosteal flap; in group 3, 20 µg of rhBMP-2 was added to the OPLA-HY matrix; and in group 4, the femoral defect containing the OPLA-HY matrix and 20 µg of rhBMP-2 was wrapped circumferentially by the vascularized periosteal flap. The presence and density of new bone formation in the femoral defect were evaluated radiographically, histologically, and with histomorphometry at four and eight weeks postoperatively.

Results: Groups 1 and 2, which were not treated with rhBMP-2, showed no radiographic or histologic evidence of mature bone formation at four or eight weeks. Both groups 3 and 4, which were treated with rhBMP-2, demonstrated excellent bone formation. However, with the periosteal flap, group 4 demonstrated more bone formation on histomorphometric analysis at eight weeks (43.1%) than did group 3 (28.3%) (p < 0.01). Additionally, heterotopic bone formed outside the boundaries of the defect in eight of the fifteen animals in group 3, which had no periosteal flap.

Conclusions: Bone-tissue engineering with use of the OPLA-HY matrix and rhBMP-2 produced good bone formation in the rat femoral defect model. However, the addition of a vascularized periosteal flap significantly increased bone formation within the boundaries of the defect and prevented heterotopic ossification.

Clinical Relevance: This tissue-engineering technique may provide another option for reconstruction of segmental bone defects and chronic nonunions, especially those associated with a defective wound environment, as an alternative to conventional bone-grafting techniques.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 JBJSHome page
Y. Khan, M. J. Yaszemski, A. G. Mikos, and C. T. Laurencin
Tissue Engineering of Bone: Material and Matrix Considerations
J. Bone Joint Surg. Am., February 1, 2008; 90(Supplement_1): 36 - 42.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
H. J. Seeherman, K. Azari, S. Bidic, L. Rogers, X. J. Li, J. O. Hollinger, and J. M. Wozney
rhBMP-2 Delivered in a Calcium Phosphate Cement Accelerates Bridging of Critical-Sized Defects in Rabbit Radii
J. Bone Joint Surg. Am., July 1, 2006; 88(7): 1553 - 1565.
[Abstract] [Full Text] [PDF]